Clinical Trial Update: Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of the ChAdOx2 RabG rabies vaccine was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• ChAdOx2 RabG

Snippet

Sponsor: University of Oxford | Conditions: Rabies | Phase 1 | Status: TERMINATED